Health Care & Life Sciences » Biotechnology | Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Fennec Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Eventide Healthcare & Life Sciences Fund
741,175
3.92%
0
1.02%
06/29/2018
Putnam Global Health Care Fund
238,221
1.26%
0
0.16%
06/30/2018
iShares Russell 2000 ETF
237,213
1.25%
-126
0.01%
09/06/2018
iShares Russell 2000 Growth ETF
112,962
0.6%
0
0.01%
09/06/2018
USAA Small Cap Stock Fund
55,348
0.28%
9,500
0.03%
06/30/2018
iShares Micro Cap ETF
30,410
0.16%
0
0.03%
09/06/2018
Putnam Variable Trust - Global Health Care Fund
25,212
0.13%
0
0.16%
06/30/2018
Schwab Small Cap Index Fund
21,100
0.11%
21,100
0.01%
06/30/2018
20,043
0.11%
0
0.01%
07/31/2018
17,500
0.09%
-500
0.18%
05/31/2018

About Fennec Pharmaceuticals

View Profile
Address
Research Triangle Park
Durham North Carolina 27709
United States
Employees -
Website http://www.fennecpharma.com
Updated 07/08/2019
Fennec Pharmaceuticals, Inc. is a small stage biotechnology company, which engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.